相关实验视频

Updated: Sep 9, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

在急性髓性白血病 (AML) 中整合多种方法:进展和临床影响

Hamed Soleimani Samarkhazan¹

¹Student Research Committee, Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. hamed.soleimani.s@gmail.com.

Clinical and experimental medicine

|August 31, 2025

概括

通过整合多种数据类型,多种方法正在彻底改变急性髓性白血病 (AML) 的研究. 这种整合增强了对疾病复杂性的理解,从而改善了诊断和个性化治疗以获得更好的患者结果.

科学领域:

血液学
癌症学
基因组学

背景情况:

由于复杂性和耐药性,急性髓性白血病 (AML) 是一种侵袭性癌症,结果不佳.
目前的治疗方法面临疾病异质性和高复发率的挑战.

研究的目的:

审查在洗钱研究中多种经济学整合的变革性影响.
突出技术的进步,生物标志物发现和治疗策略.

主要方法:

多基因组学数据的整合:基因组学,表观基因组学,转录基因组学,蛋白质组学和代谢组学.
高通量测序,质谱和计算工具的应用.
单细胞数据和蛋白质基因组资料的分析.

主要成果:

发现了新的生物标志物,克隆进化动态和微环境相互作用.
已确定耐化疗白血病干细胞和可操作的点,如MCL1.
发现了代谢依赖,例如OXPHOS.

结论:

多种病原体的整合提供了对AML病原体和异质性的全面了解.
这些方法完善了风险分层,MRD监测和个性化治疗选择.
多种药物有望重新定义AML管理,

关键词:

急性骨髓性白血病 (AML)生物标志物多种经济一体化精确瘤学治疗目标

更多相关视频

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...